Clinical trials
Withdrawn Phase 1/2 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhujiang Hospital | 2 |
| Celgene | 1 |
| Dizal Pharmaceuticals | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| GlaxoSmithKline | 1 |
| Kunming Hope of Health Hospital | 1 |
| M.D. Anderson Cancer Center | 1 |
| RedHill Biopharma Limited | 1 |
| Triumvira Immunologics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 12 |
| Lymphoma | 3 |
| Burkitt Lymphoma | 2 |
| Leukemia, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Disease | 1 |
| Epstein-Barr Virus Infections | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.